Report
Valens Research

IFF - Embedded Expectations Analysis - 2021 08 10

International Flavors & Fragrances, Inc. (IFF:USA) currently trades at a historical high relative to UAFRS-based (Uniform) earnings, with a 31.8x Uniform P/E. At these levels, the market is pricing in bullish expectations for the firm, but management may have concerns about sales performance in several segments, integration plan execution, and costs.

Specifically, management is confident increases in the Health and Home & Personal Care segments were offset by pressures in Microbial Control and Grain Processing. Additionally, they may lack confidence in their ability to sustain sales performance in several segments, drive overall group operating efficiencies while executing integration plans, and meet their three-year run rate synergy target of $400 million. Moreover, management may have concerns about raw material availability and distribution costs being impacted by the shutdown of two plants, the time lag in input costs for some legacy F&F businesses, and pandemic-driven headwinds in Food Design driven by continued declines in Food Service.
Underlying
International Flavors & Fragrances Inc.

International Flavors & Fragrances is a creator and manufacturer of taste, scent and complementary adjacent products, including cosmetic active and natural health ingredients. The company's operating segments are Taste and Scent. The Taste segment develops a range of different flavors and taste offerings for its customers, most of which are tailor-made. The company's Taste business is comprised of various portfolios across flavor compounds, savory solutions, inclusions and nutrition and specialty ingredients. The Scent segment creates fragrance compounds and fragrance ingredients for the household and personal care products. The company also produces cosmetic active and functional ingredients for use in cosmetics.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch